| Date Filed | Type | Description |
| 05/26/2023 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.12, valued at
$16.8k
|
|
| 07/15/2019 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.31, valued at
$45.9k
|
|
| 05/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2018 |
4/A
| CANNON MICHAEL D (See Remarks) has filed a Form 4 on Athenex, Inc.|
Txns:
| Granted 18,000 options to buy
@ $11, valued at
$198k
|
|
| 06/08/2018 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.82, valued at
$63.7k
|
|
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 09/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |